La Differenza tra Ricerca Medica in Italia e in Altri Paesi.
Come ho spesso riferito, nessuna competente autorità sanitaria italiana, incluso il mio Onorevole Ordine dei Medici di Genova ha mai risposto alle mie mail e alle mie numerose Lettere Aperte, in 63 anni di ricerche cliniche, sconosciute solo in Italia.
Quanto segue per dimostrare, se mai ve ne fosse il bisogno, che solo in questo Paese non esiste collaborazione tra gli studiosi e che ai competenti Ministri e ai Direttori di Istituti scientifici non interessa affatto le scoperte di chi nuota lontano dalla mainstream, seguendo originali ricerche, magari non politicamente corrette.
Dopo aver inviato una e-Letter (V. Avanti) agli Editori di Science, ho scritto una mail agli Autori:
Dear Prof. Bert Vogelstein,
Dear Prof. Cristian Tomasetti,
Congratulations. Your article is fascinating. In following, the comment I have sent yerstarday:
http://science.sciencemag.org/content/355/6331/1330/tab-e-letters
Ed ecco la pronta risposta:
——- Messaggio Inoltrato ——–
Oggetto: | RE: My comment under moderation |
Data: | Thu, 30 Mar 2017 11:42:45 -0400 |
Mittente: | Bert Vogelstein <bertvog@gmail.com> |
A: | ‘Sergio Stagnaro’ <dottsergio@semeioticabiofisica.it> |
CC: | ‘Cristian Tomasetti’ <ctomasetti@jhu.edu> |
Hi Sergio –
Thanks for your comment and for sharing your letter with us.
Bert
Bert Vogelstein
Director, Ludwig Center at Johns Hopkins
Investigator, Howard Hughes Medical Institute
Scholar, Lustgarten Foundation
1650 Orleans Street, Room 589
Baltimore, MD 21287
Phone: 410.955.8878
Fax: 410.955.0548
email: bertvog@gmail.com
_________________________________________________________________________
Di seguito il testo della mia e-Letter, pubblicata dopo mederazione, anche se chiaramente critica, ma costruttiva:
http://science.sciencemag.org/content/355/6331/1330/tab-e-letters
RE: H, E, and R factors of cancer onset
- Sergio Stagnaro, Director, Quantum Biophysical Semeiotic Research Laboratory
- Other Contributors:
- Marco Marchionni, Neurosurgery, Department of Neurosurgery University Hospital of North Staffordshire Stoke on Trent, UK
- Simone Caramel, President, International Society of Quantum Biophysical Semeiotic
(29 March 2017)
The recent publication by Tomasetti et al. in Science appears as a fascinating contribution to solving a central problem, till now open, in oncogenesis. As a matter of fats, because such a R factors do not act in all individuals, we unavoidably and necessarily have to admit the existence of something heritable somewhere in human body. Really, we are not all born equal. I think that the site of a possible inherited “mutation” could be the mitochondria. In fact, mitochondria play notoriously a flurry of biologically essential functions, among them proteine-lipid-glucose metabolism regulation, Fe metabolism control, Fe/S-Cluster production in its assembly machinary (CIA is working exclusively in presence of a substance, till now only partially known, i.e., XS, that is synthetized in mitocondria), n-DNA duplication, and Telomere lenght regulation, realized by the action of Fe/S-Cluster via RTL-1 and -2. In conclusion, if this theory on the central role of mitochondria in oncology will be supported on very large scale, it opens an interesting therapeutic way to combat oncogenesis.
In Italia non ho mai ottenuto la possibilità di dialogare costruttivamente ed apertamente con nessun docente di Medicina dell’establishment, per confrontare le nostre differenti teorie. La conseguenza del desolante comportamento è il fatto che in Italia sono sconosciuti i Reali Rischi Congeniti dipendenti dalle relative Costituzioni semeiotico-biofisico-quantistiche, diagnosticati dalla nascita con un fonendoscopio ed eliminati con non costosa Terapia Quantistica Mitocondriale Ristrutturante.
- RE: mtDNA mutations may affect random nuclear DNA mutations of Stem cells
- Vasilios Makropoulos, Professor, National School of Public Health, Athens, Greece
- Other Contributors:
- Emmanouil Papadogiannakis, Assist. Professor, National School of Public Health, Athens, Greece
- Gregory Spanakos, Biologist PhD, National School of Public Health, Athens, Greece
- Kostas Kotrokois, Assist Professor, National School of Public Health, Athens, Greece
(4 April 2017)
The recent publication by Tomasetti et al., in Science concludes that DNA replication errors (R) of normal Stem cell divisions are responsible for two-thirds of the mutations in human cancers.
We fully agree with Sergio Stagnaro et al., response to this article that the site of a possible “mutation” could be the mitochondria. Tomasetti et al., did not focus on mtDNA of Stem cells for possible mutations. According to novel scientific findings, there is a significant interplay between mitochondria and the cell nucleus. Mutations in the nucleus could be the result of mtDNA mutations, and therefore the former could not be called “random”.
Da quanto precede si comprende perché una nostra Università è classificata prima al mondo solo perché nata prima delle altre: https://www.topuniversities.com/blog/10-oldest-universities-world